Last $9.87 USD
Change Today +0.33 / 3.46%
Volume 650.1K
IG On Other Exchanges
As of 8:04 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

igi laboratories inc (IG) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/3/14 - $11.28
52 Week Low
02/4/14 - $3.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IGI LABORATORIES INC (IG)

Related News

No related news articles were found.

igi laboratories inc (IG) Related Businessweek News

No Related Businessweek News Found

igi laboratories inc (IG) Details

IGI Laboratories, Inc. develops, manufactures, and markets topical formulations in the United States. The company sells its generic topical pharmaceutical products under the IGI label. It also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter (OTC) and cosmetic markets. The company’s products are used in various applications from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, it offers pharmaceutical contract services comprising formulating, testing, and/or manufacturing prescription pharmaceutical products and medical devices; and contract development services consisting of developing topical formulations for the pharmaceutical, OTC, and cosmetic customers. IGI Laboratories, Inc. has a license agreement with Novavax, Inc. to utilize the Novasome lipid vesicle encapsulation and certain other technologies for applications in animal pharmaceuticals, biologicals, and other animal health products; foods, food applications, nutrients, and flavorings; cosmetics, consumer products, and dermatological OTC and prescription products; fragrances; and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals, and other specialty chemicals. The company was formerly known as IGI, Inc. and changed its name to IGI Laboratories, Inc. in May 2008. IGI Laboratories, Inc. was founded in 1977 and is headquartered in Buena, New Jersey.

52 Employees
Last Reported Date: 03/31/14
Founded in 1977

igi laboratories inc (IG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $565.3K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $261.2K
Compensation as of Fiscal Year 2013.

igi laboratories inc (IG) Key Developments

IGI, Laboratories, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 10:30 AM

IGI, Laboratories, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 10:30 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Jason Grenfell-Gardner, Chief Executive Officer, President and Director, Jenniffer L. Collins, Chief Financial Officer, Principal Accounting Officer and Secretary.

IGI Laboratories, Inc. Announces Three Additional ANDA Submissions

IGI Laboratories, Inc. announced it has submitted three additional abbreviated new drug applications (ANDAs) to the U.S. Food and Drug Administration (FDA), which brings the company's total number of ANDA submissions in 2014 to eleven, with twenty-two submissions now pending at the FDA.

IGI, Laboratories Seeks Acquisitions

IGI, Laboratories, Inc. (AMEX:IG) intends to offer $125 million principal amount of convertible senior notes due 2019. IGI intends to use the net proceeds from the sale of the notes for general corporate purposes, including, without limitation, capital expenditures and potential future acquisitions and strategic transactions. IGI has no pending agreement or understanding with respect to any such acquisition or transaction.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IG:US $9.87 USD +0.33

IG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Taro Pharmaceutical Industries Ltd $165.17 USD +2.21
View Industry Companies

Industry Analysis


Industry Average

Valuation IG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 18.7x
Price/Book 15.3x
Price/Cash Flow 1,730.6x
TEV/Sales 17.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IGI LABORATORIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at